HomeOpen Access NewsCommunicable Diseases

Communicable Diseases

New tools help track and contain deadly avian flu

Scientists have developed new tests that can detect avian influenza, which is also commonly known as bird flu. These tests can detect influenza quickly and more accurately than ever before.

Ebola haemorrhagic fever outbreak in Democratic Republic of the Congo

A new case of Ebola haemorrhagic fever has been detected in the Democratic Republic of Congo - healthcare experts say "time is not on our side".

Filling in the gaps of brain immune response

Open Access Government spoke to Dr Robyn S. Klein, MD, PhD, about her ground-breaking work in neuroimmunology and the path to understanding the links between viral encephalitis and memory disorders.

New pandemic of antibiotic resistance makes pneumonia deadly

In Bangladesh, children are fighting a difficult battle to survive antibiotic resistance - now, mid-pandemic, pneumonia is becoming untreatable via normal drugs.

Diphtheria slowly becomes resistant to antimicrobial treatment

There is a well-established diphtheria vaccine taken by millions of people, but researchers are now observing the disease evolving a resistance to antimicrobial treatment.

Pfizer vaccine can reduce COVID hospitalisation and death by 75%

Early stage data from the vaccine rollout in the UK appears to show that COVID hospitalisation and death are reduced by over 75% in people with the Pfizer vaccine.

ECMO machine reduces COVID-19 deaths by 45% for “sickest patients”

According to data collected by 400 healthcare professionals at the worst moment of the US outbreak, the life support machine that acts in place of the heart and lungs is crucial to reducing COVID-19 deaths for the critically ill.

Consequences of foetal development in a “sweet” uterus: The short-and long-term transgenerational outcomes

Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.

The Moderna vaccine has a final efficiency of 94.1%

The clinical trials are over for the Moderna vaccine - the company announced their drug was 94.1% effective and then filed for Emergency Use.

Medical authorities call for better HIV testing in Europe

The European Centre for Disease Control (ECDC) and the World Health Organisation (WHO) found that HIV testing in Europe is not good enough - 53% of diagnosis happens when the immune system is already failing.

COVID-19 in New York: The outbreak came from atleast 109 sources

Researchers have investigated the origins of COVID-19 in New York - from the sources that started the infection, to how it spread through the population.

Expert comment: Now is the time to prepare for the next pandemic

Professor Martin Michaelis and Dr Mark Wass, University of Kent, School of Biosiences, say it is crucial to overcome COVID-19 and to prepare for the next pandemic.

How to support local businesses during lockdown

Do you want to help support the local businesses in your area during the COVID-19 lockdown? You can do so safely in these three simple ways.

The science behind the Hong Kong COVID-19 strategy

Currently, the country has only experienced four deaths: What is the Hong Kong COVID-19 strategy and why is it working so well?

How can you protect yourself from catching Coronavirus?

Coronavirus is now a potent word: We dilute the fake news down to facts, describing the WHO approved methods to protect you from catching Coronavirus.

COVID-19 research: How long does it take for symptoms to show?

Infectious disease experts engaged in COVID-19 research have identified how quickly the virus can spread.

COVID-19 research: Scientists prove that China did not create coronavirus

Conspiracy theorists can now take COVID-19 research off their radar: Scripps Research analysed the virus and found that it was not created by China.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders